In This Issue: •Do the Opposite: Recent sentiment figures show plenty of fear, but the bears remain stubbornly cautious. They should know better.
•STARS Status: Changes in S&P analysts' STARS rankings for August 28 through September 1.
•Home Prices on Shaky Ground: A new S&P index indicates that home prices nationwide could fall 6% by May 2007.
•Royal Blue Chips: Stocks with above-average earnings growth and steadily increasing dividends can reward you with a princely sum over time.
•Drug Stocks Come Back to Life: Fund managers say the recent turnaround in pharmaceutical stocks is a sign of healthier times ahead. S&P Equity Strategy agrees.
•The Nurse Is In: Drugstore chains are branching out, and the investment implications are significant.
•Master List Stocks Update: Our three supervised Master List groups of stocks, recommended as core holdings for long-term investors, are regularly featured on these two pages. The Total Return Portfolio, highlighted this week, consists of stocks we like for income.
•Industry Momentum Portfolio: This S&P portfolio identifies industry sectors with potential for above-average price performance. Some of the Companies Featured: Abbott Laboratories
Advent Software
Bristol-Myers Squibb
Brown & Brown
Capital One
Crucell
Devon Energy
Enterprise GP Holdings
Global Payments
Home Depot
IndyMac
Lehman Brothers Holdings
Scottish Power
Semtech
SunTrust Banks | 
